Cognizant to Report Q3 Earnings: What's in Store for the Stock? — Positive
CTSH Zacks Investment Research — October 27, 2025CTSH's third-quarter 2025 performance is likely to have benefited from an expanding clientele and a robust pipeline that includes a favorable mix of new opportunities.
Ryder Tops Q3 Earnings Estimates, Improves Y/Y, Tweaks 2025 EPS View — Positive
R Zacks Investment Research — October 27, 2025R's third-quarter 2025 earnings reflect higher contractual earnings and share repurchases.
Meta's CTO said the metaverse unit is reshuffling. Read the memos. — Neutral
META Business Insider — October 27, 2025Meta reorganizes its metaverse unit, shifting Vishal Shah to its AI division, per an internal memo. Gabriel Aul and Ryan Cairns now lead Meta's metaverse efforts, focusing on VR and mobile.
OPFI vs. SOFI: Which Fintech Credit Stock Is the Better Buy Right Now? — Positive
OPFI SOFI Zacks Investment Research — October 27, 2025OppFi's niche subprime strategy and rising earnings contrast with SoFi Technologies' scale-driven growth and expanding profitability. Let us determine which fintech stock looks stronger now.
Novanta (NOVT) Surges 8.3%: Is This an Indication of Further Gains? — Positive
NOVT Zacks Investment Research — October 27, 2025Novanta (NOVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
IDCC Set to Report Q3 Results: Will Revenue Growth Boost Earnings? — Positive
IDCC Zacks Investment Research — October 27, 2025InterDigital targets Q3 growth driven by new smartphone licensing deals and strong focus on innovation.
SOFI Technologies to Report Q3 Earnings: Here's What to Expect — Positive
SOFI Zacks Investment Research — October 27, 2025SOFI is set to report Q3 results, with revenue and earnings expected to show strong double-digit growth.
Nvidia: A Prime Beneficiary Of The $4 Trillion AI Opportunity — Positive
NVDA Seeking Alpha — October 27, 2025Nvidia Corporation reported strong Q2 FY26 results, with 55% growth across its consolidated topline, driven by robust AI-related demand. NVDA's Blackwell GB300 platform adoption in the data centers end market and tailwinds from global AI infrastructure spending are expected to fuel growth in FY26 and beyond. Despite trading at a premium, NVDA's unrivaled AI leadership and strong double-digit growth expectations keep NVDA stock a solid Buy for the long term.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie — Neutral
JHX GlobeNewsWire — October 27, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options
Should Verizon Stock Be in Your Portfolio Pre Q3 Earnings? — Negative
VZ Zacks Investment Research — October 27, 2025VZ faces sliding earnings estimates and weakness in business segment as it readies Q3 results amid fierce wireless competition.
Invitation Homes to Report Q3 Earnings: What to Expect From the Stock? — Neutral
INVH Zacks Investment Research — October 27, 2025INVH's Q3 results are likely to reflect strong demand for single-family rentals and tech-driven margin gains amid supply pressures.
Republic Services to Report Q3 Earnings: Here's What You Should Know — Negative
RSG Zacks Investment Research — October 27, 2025RSG's third-quarter 2025 results are likely to witness revenue growth despite margin pressure weighing on earnings.
Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025 — Neutral
EW Business Wire — October 27, 2025SAN FRANCISCO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm pivotal trial achieved all primary and secondary endpoints for safety and effectiveness, with outcomes simultaneously published in The Lancet. Thirty-day data from the EVOQUE system STS/ACC TVT Registry, the largest real-world transcatheter tricuspid valve replacement.
Why Lululemon's NFL collaboration could be more of a ‘Hail Mary' than a touchdown — Negative
LULU Market Watch — October 27, 2025Shares of Lululemon Athletica Inc. ran higher on Monday, after the company announced it is working with the National Football League on a new clothing line. But one analyst said the move underscored some of the yoga-wear maker's bad habits.
Trucker Path and WEX® Team Up to Offer Fuel Discounts to More Than 1 Million App Users — Neutral
WEX PRNewsWire — October 27, 2025Trucker Path app users to gain access to fuel savings via the 10-4 by WEX™ app PORTLAND, Maine and PHOENIX , Oct. 27, 2025 /PRNewswire/ -- Trucker Path , the most comprehensive and relied upon mobile app for North American truckers, and WEX ® (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced that the fuel discounts offered on the 10-4 by WEX™ app will be available to the Trucker Path community. This integration provides Trucker Path app users with access to fuel discounts provided by the 10-4 by WEX app.
Fuel cell power stock Bloom Energy Inc (NYSE:BE) is moving lower ahead of its third-quarter earnings report, due out after the close tomorrow, October 28.
Frank Talk: The West fights back in the rare earth wars — Neutral
GROW Proactive Investors — October 27, 2025China's tightening grip on the world's rare earth supply could mark a turning point in the global race for critical minerals, writes Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW).
Tesla has ‘solved' autonomous driving, says one analyst. This could change the game. — Positive
TSLA Market Watch — October 27, 2025Conventional wisdom calls for driverless vehicles equipped with an array of tech. Tesla went for a cheaper option and seems to be having success.
CHWY vs. CENT: Which Pet-Care Stock Has Stronger Growth Momentum? — Positive
CENT CHWY Zacks Investment Research — October 27, 2025Chewy's accelerating sales and expanding pet-care platform outpace Central Garden & Pet's margin-focused but slower growth strategy.
AXT (AXTI) Soars 17.0%: Is Further Upside Left in the Stock? — Positive
AXTI Zacks Investment Research — October 27, 2025AXT (AXTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.